Have you noticed a change in the WSJ Health Blog after I commented that "Frankly, aside from the headlines, it's a little bland"?
Take today's post, "John Johnson Leaving Johnson & Johnson", for example. Let me reproduce the whole thing here:
John Johnson is leaving Johnson & Johnson to run ImClone Systems.Now that's funny!
No word on whether John H. Johnson (pictured, left) is related to Robert Wood Johnson (pictured, right) or Edward Mead Johnson, founders of Johnson & Johnson.
But regardless of any connections among Messrs. Johnson, we have to wonder whether Johnson will be glad to be free of the possible confusion of being John Johnson at Johnson & Johnson. (We called Johnson & Johnson and got John Johnson's voicemail, but didn't hear back.)
We checked in with Avery Johnson, WSJ's Johnson & Johnson reporter (who doesn't think she's related to Johnson, Johnson or Johnson), but our Johnson hadn't spoken with John Johnson.
What we do know is that Johnson, 49, has been company group chairman of J&J's world-wide biopharmaceuticals unit. He starts his job at ImClone later this month.
Financier and ImClone chairman Carl Icahn welcomed Johnson aboard. "We look forward to working with him to take the company to the next level," Icahn said in a statement.
The post was made by Jacob Goldstein. Nice job!